Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
39.30
-2.42 (-5.80%)
At close: Jul 2, 2024, 4:00 PM
40.33
+1.03 (2.62%)
After-hours: Jul 2, 2024, 5:15 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.04 billion as of July 2, 2024. Its market cap has increased by 289.70% in one year.
Market Cap
2.04B
Enterprise Value
1.41B
1-Year Change
289.70%
Ranking
Category
Stock Price
$39.30
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.04B, an increase of 232.03%. That is a compound annual growth rate of 48.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 2.16B | 336.66% |
| Dec 29, 2023 | 495.40M | -9.71% |
| Dec 30, 2022 | 548.70M | -33.17% |
| Dec 31, 2021 | 821.00M | 33.77% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.23B |
| Certara | 2.23B |
| QuidelOrtho | 2.22B |
| Evolent Health | 2.22B |
| Myriad Genetics | 2.21B |
| Indivior | 2.16B |
| Intellia Therapeutics | 2.16B |
| CONMED | 2.14B |